Total Debt Summary of TaiMed Biologics Inc.

TaiMed Biologics Inc.'s latest annual total debt in 2023 was 750.85 Million TWD , down -2.0% from previous year.
TaiMed Biologics Inc.'s latest quarterly total debt in 2024 Q2 was 537.14 Million TWD , down -27.77% from previous quarter.
TaiMed Biologics Inc. reported annual total debt of 766.14 Million TWD in 2022, up 35.04% from previous year.
TaiMed Biologics Inc. reported annual total debt of 567.32 Million TWD in 2021, down -0.34% from previous year.
TaiMed Biologics Inc. reported quarterly total debt of 537.14 Million TWD for 2024 Q2, down -27.77% from previous quarter.
TaiMed Biologics Inc. reported quarterly total debt of 750.85 Million TWD for 2023 Q4, down -0.85% from previous quarter.

Annual Total Debt Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Total Debt of TaiMed Biologics Inc. (2023 - 2009)

Year	Total Debt	Total Debt Growth
2023	750.85 Million TWD	-2.0%
2022	766.14 Million TWD	35.04%
2021	567.32 Million TWD	-0.34%
2020	569.25 Million TWD	1574.46%
2019	33.99 Million TWD	0.0%
2018	- TWD	0.0%
2017	- TWD	0.0%
2016	- TWD	0.0%
2015	- TWD	0.0%
2014	- TWD	0.0%
2013	- TWD	0.0%
2012	- TWD	0.0%
2011	- TWD	0.0%
2010	- TWD	0.0%
2009	- TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	743.62 Million TWD	-0.96%
2024 Q2	537.14 Million TWD	-27.77%
2023 Q4	750.85 Million TWD	-0.85%
2023 Q1	765.63 Million TWD	-0.07%
2023 FY	750.85 Million TWD	-2.0%
2023 Q3	757.29 Million TWD	-0.93%
2023 Q2	764.42 Million TWD	-0.16%
2022 Q2	767.14 Million TWD	35.34%
2022 Q1	566.83 Million TWD	-0.09%
2022 FY	766.14 Million TWD	35.04%
2022 Q4	766.14 Million TWD	-0.07%
2022 Q3	766.64 Million TWD	-0.07%
2021 Q4	567.32 Million TWD	-3.81%
2021 Q2	675.03 Million TWD	-0.23%
2021 Q1	676.55 Million TWD	18.85%
2021 Q3	589.77 Million TWD	-12.63%
2021 FY	567.32 Million TWD	-0.34%
2020 Q3	569.73 Million TWD	-0.08%
2020 FY	569.25 Million TWD	1574.46%
2020 Q1	33.53 Million TWD	-1.37%
2020 Q2	570.2 Million TWD	1600.54%
2020 Q4	569.25 Million TWD	-0.08%
2019 Q4	33.99 Million TWD	-1.33%
2019 FY	33.99 Million TWD	0.0%
2019 Q1	35.36 Million TWD	0.0%
2019 Q2	34.91 Million TWD	-1.29%
2019 Q3	34.45 Million TWD	-1.31%
2018 FY	- TWD	0.0%
2018 Q4	- TWD	0.0%
2018 Q3	- TWD	0.0%
2018 Q2	- TWD	0.0%
2018 Q1	- TWD	0.0%
2017 FY	- TWD	0.0%
2017 Q4	- TWD	0.0%
2017 Q3	- TWD	0.0%
2017 Q2	- TWD	0.0%
2017 Q1	- TWD	0.0%
2016 Q3	- TWD	0.0%
2016 Q1	- TWD	0.0%
2016 FY	- TWD	0.0%
2016 Q4	- TWD	0.0%
2016 Q2	- TWD	0.0%
2015 Q3	- TWD	0.0%
2015 FY	- TWD	0.0%
2015 Q4	- TWD	0.0%
2015 Q2	- TWD	0.0%
2015 Q1	- TWD	0.0%
2014 Q2	- TWD	0.0%
2014 Q4	- TWD	0.0%
2014 Q1	- TWD	0.0%
2014 FY	- TWD	0.0%
2013 Q1	- TWD	0.0%
2013 Q2	- TWD	0.0%
2013 Q3	- TWD	0.0%
2013 Q4	- TWD	0.0%
2013 FY	- TWD	0.0%
2012 Q3	- TWD	0.0%
2012 Q2	- TWD	0.0%
2012 Q4	- TWD	0.0%
2012 FY	- TWD	0.0%
2011 FY	- TWD	0.0%
2011 Q2	- TWD	0.0%
2011 Q4	- TWD	0.0%
2010 Q4	- TWD	0.0%
2010 FY	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Total Debt Comparison of TaiMed Biologics Inc.

Name	Total Debt	Total Debt Difference
Bio Preventive Medicine Corp.	113.44 Million TWD	-561.855%
Genomics BioSci & Tech. Co.,Ltd.	283.61 Million TWD	-164.748%
Advagene Biopharma Co., Ltd.	870 Thousand TWD	-86205.172%
Taiwan Bio Therapeutics Co., Ltd	268.62 Million TWD	-179.521%
NaviFUS Corp.	32.69 Million TWD	-2196.684%
G&E Herbal Biotechnology Co., Ltd.	5.43 Million TWD	-13725.354%
TaiRx, Inc.	12.28 Million TWD	-6011.468%
Sinew Pharma Inc.	6.46 Million TWD	-11515.95%
Lin BioScience, Inc.	42.87 Million TWD	-1651.347%
TaiwanJ Pharmaceuticals Co., Ltd.	1.17 Million TWD	-64020.837%
Lumosa Therapeutics Co., Ltd.	12.61 Million TWD	-5854.441%
Anti-Microbial Savior BioteQ Co., Ltd	1.38 Million TWD	-54191.757%
SYN-TECH Chem. & Pharm. Co., Ltd.	402.75 Million TWD	-86.431%
AP Biosciences Inc	82.07 Million TWD	-814.796%
Sunmax Biotechnology Co., Ltd.	174.08 Million TWD	-331.308%
RBC Bioscience Corporation	487.36 Million TWD	-54.065%
Syngen Biotech Co.,Ltd.	681.76 Million TWD	-10.134%
EirGenix Inc.	465.16 Million TWD	-61.416%
Enimmune corporation	45.73 Million TWD	-1541.787%
Lukas Biomedical Inc.	82.55 Million TWD	-809.521%
BRIM Biotechnology, Inc.	3.59 Million TWD	-20803.536%
3D Global Biotech Inc.	10.37 Million TWD	-7134.367%
Mycenax Biotech Inc.	726.27 Million TWD	-3.384%
TCI GENE Inc.	6.79 Million TWD	-10950.11%
SynCore Biotechnology Co.,Ltd	2.11 Million TWD	-35418.212%
Oneness Biotech Co., Ltd.	397.95 Million TWD	-88.681%
Eusol Biotech Co.,Ltd.	4.35 Million TWD	-17145.177%
Feng Chi Biotech Corp.	10.79 Million TWD	-6853.649%
NeoCore Technology Co., Ltd.	96.89 Million TWD	-674.948%
TWi Biotechnology, Inc.	7.97 Million TWD	-9319.834%
Neith Corporation	3.54 Million TWD	-21104.603%
Sunny Pharmtech Inc.	391.42 Million TWD	-91.825%
VBI	- TWD	-Infinity%
Ever Supreme Bio Technology Co., Ltd	5.89 Million TWD	-12630.671%
GeneReach Biotechnology Corp.	257.03 Million TWD	-192.118%
Shine-On BioMedical Co.,Ltd.	538 Thousand TWD	-139464.126%
CHO Pharma, Inc.	- TWD	-Infinity%
Andros Pharmaceuticals Co.,Ltd	27.12 Million TWD	-2668.537%
MegaPro Biomedical Co., Ltd	8.31 Million TWD	-8926.869%
Visgeneer Inc.	158.6 Million TWD	-373.409%
Greenyn Biotechnology Co., Ltd	196.13 Million TWD	-282.828%
BioLASCO Taiwan Co., Ltd.	58.2 Million TWD	-1189.996%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	417.01 Million TWD	-80.054%
Sagittarius Life Science Corp	13.32 Million TWD	-5535.78%
BioGend Therapeutics Co., Ltd.	13.09 Million TWD	-5635.22%
GlycoNex Incorporation	900 Thousand TWD	-83328.333%
Medigen Biotechnology Corp.	2.91 Billion TWD	74.212%
Pharmosa Biopharm Inc.	144.36 Million TWD	-420.094%
PharmaEngine, Inc.	14.8 Million TWD	-4970.261%
Intech Biopharm Corporation	1.43 Billion TWD	47.678%
Taiwan Advance Bio-Pharmaceutical Inc.	320.13 Million TWD	-134.546%
BiOptic Inc.	93.19 Million TWD	-705.656%
TaiGen Biopharmaceuticals Holdings Limited	74.68 Million TWD	-905.336%
Senhwa Biosciences, Inc.	9.6 Million TWD	-7720.592%
NatureWise Biotech & Medicals Corporation	10.68 Million TWD	-6929.161%
OBI Pharma, Inc.	501.05 Million TWD	-49.855%
Savior Lifetec Corporation	270.37 Million TWD	-177.708%
Great Novel Therapeutics Biotech & Medicals	14.37 Million TWD	-5123.339%
Level Biotechnology Inc.	13.5 Million TWD	-5461.065%
Medigen Vaccine Biologics Corporation	1.97 Billion TWD	61.971%
Meribank Biotech Co., Ltd	34.03 Million TWD	-2105.867%
Acepodia, Inc.	273.81 Million TWD	-174.224%
Caliway Biopharmaceuticals Co., Ltd.	20.45 Million TWD	-3570.227%

Global Stocks Search

TaiMed Biologics Inc. (4147.TWO)

Total Debt Summary of TaiMed Biologics Inc.

Annual Total Debt Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Total Debt of TaiMed Biologics Inc. (2023 - 2009)

Peer Total Debt Comparison of TaiMed Biologics Inc.